Earnings Releases
Quarterly 2024
Q4 & Full Year 2024 Earnings Conference Call
Annual
2024
Annual
2018
Annual
2017
Annual
2016
Annual
2015
Annual
2014
Annual
2013
Annual
2012
Annual
2011
Annual
2010
Annual
2009
Annual
2008
"Genomma delivered strong Q4 and full-year results, with Net Sales increasing 32.4% and 13.0%, respectively. EBITDA margin expanded to 24.0% in Q4 and 23.3% for the year, rising 351 and 235 basis points, driven by productivity gains.Full-year EPS doubled to 2.14 while Free Cash Flow hit a record Ps. 2.8 billion, a 36% increase. We achieved steadygrowth across key markets and brands, with notable profitability gains in 2024. Looking ahead, we will strengthen corebrands by reinvesting savings from productivity gains as we pursue our cost savings target of Ps. 1.8 billion by 2027."
Marco Sparvieri
Chief Executive Officer
February 26, 2025
